ARTICLE | Clinical News
Arriva preclinical data
September 6, 2004 7:00 AM UTC
In a mouse model of smoke-induced COPD, recombinant AAT prevented up to 73% of the lung tissue damage caused by cigarette smoke in treated animals as compared to untreated animals. Data will be presen...